Skip to main content
Federal & State Lawfederalstatelaw.com
Home/Federal/Bills (Live)
HOUSE 2940118th CongressReferred to the Subcommittee on Health.

PASTEUR Act

Last Action
12/17/2024

Actions

  • 2024-12-17Referred to the Subcommittee on Health.
  • 2023-04-28Referred to the Subcommittee on Health.
  • 2023-04-27Referred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Accountability, Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2023-04-27Referred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Accountability, Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2023-04-27Referred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Accountability, Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2023-04-27Referred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Accountability, Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2023-04-27Introduced in House
  • 2023-04-27Introduced in House

CRS Summary

As of 2023-04-27 (00)

Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2023 or the PASTEUR Act of 2023

This bill authorizes the Department of Health and Human Services (HHS) to enter into subscription contracts for critical-need antimicrobial drugs, provides $6 billion in appropriations for activities under the bill, and contains other related provisions.

A manufacturer of a Food and Drug Administration-approved antimicrobial drug may apply to HHS to have the drug designated as a critical-need antimicrobial, and HHS may enter into a subscription contract for such a critical-need antimicrobial. The bill imposes certain requirements related to such contracts, including a mechanism to lower payments under the contract in certain instances to limit the manufacturer's revenue from the drug.

Furthermore, HHS and the Centers for Disease Control and Prevention (CDC) shall award grants to support efforts to encourage the appropriate use of antimicrobial drugs and efforts to combat antimicrobial resistance. The CDC shall also track and assess data relating to antibacterial resistance and human antibiotic use and make such data publicly available.

HHS shall also establish a Committee on Critical Need Antimicrobials. The committee shall develop a list of prioritized infections for which new antimicrobial drug development is needed, among other duties.

Within six years of the bill's enactment, the Government Accountability Office shall report to Congress a study on the bill's effectiveness in developing priority antimicrobial drugs.

Cosponsors (20)

  • Scott Peters (D-CA)
  • Jake LaTurner (R-KS)
  • Mike Levin (D-CA)
  • Mark Amodei (R-NV)
  • JAMES MCGOVERN (D-MA)
  • Maria Salazar (R-FL)
  • Brian Fitzpatrick (R-PA)
  • Earl Carter (R-GA)
  • Don Bacon (R-NE)
  • Austin Scott (R-GA)
  • Charles Fleischmann (R-TN)
  • Jake Auchincloss (D-MA)
  • Yvette Clarke (D-NY)
  • Deborah Ross (D-NC)
  • Jimmy Panetta (D-CA)
  • ELEANOR NORTON (D-DC)
  • Donald Davis (D-NC)
  • Mariannette Miller-Meeks (R-IA)
  • Mike Kelly (R-PA)
  • Jeff Duncan (R-SC)

Subjects

  • Administrative law and regulatory procedures
  • Advanced technology and technological innovations
  • Advisory bodies
  • Appropriations
  • Department of Health and Human Services
  • Drug therapy
  • Executive agency funding and structure
  • Government information and archives
  • Government studies and investigations
  • Health information and medical records
  • Infectious and parasitic diseases
  • Medical research
  • Prescription drugs
  • Public contracts and procurement
  • Research and development
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.